semaglutide eu regulator backs use of Novo's Wegovy to lower heart risks EU drugs regulator backs higher

Many Ozempic users have experienced stomach paralysis, delayed gastric emptying, deep vein thrombosis (DVT), and other gastrointestinal injuries that require ongoing medical treatment

These powerful medications, first developed to treat type 2 diabetes, are now widely used for weight loss, blood sugar control, and improving overall metabolic health

Identification of urinary acylcarnitines using gas chromatography-mass spectrometry: preliminary clinical applications

It is not snake oil

October 15, 2025: New Analysis Links Ozempic to Acute Kidney Injuries A recent analysis that examined FDA data found that Ozempic (semaglutide) is associated with acute kidney injury (AKI)